TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
Feb 04, 2026
2 min read
11

e.l.f. Beauty has increased its annual sales and profit forecasts after reporting third-quarter results that surpassed Wall Street expectations. The strong performance, driven by high demand for its affordable cosmetics, caused the company's shares to rise approximately 12% in after-hours trading.
The company has seen resilient sales in the United States as cost-conscious consumers continue to choose its lower-priced makeup and skincare products amid economic uncertainty. e.l.f. has successfully expanded its distribution network across major retailers like Target, Walmart, and Amazon, while also boosting brand awareness through a recent launch at Sephora.
Despite challenges such as U.S. import tariffs on goods from China, which accounts for a significant portion of its production, e.l.f. has managed to sustain growth. The company previously implemented a global price increase to mitigate tariff pressures, yet affirms that 75% of its products remain priced at $10 or less.
The company now projects full-year net sales between $1.60 billion and $1.61 billion, an increase from the previous forecast of $1.55 billion to $1.57 billion. For the third quarter, sales grew 38% to $489.5 million, exceeding analysts' estimates of $460.2 million.
Q: Why did e.l.f. Beauty raise its annual forecast?
A: The company raised its forecast due to better-than-expected third-quarter results, driven by strong and resilient consumer demand for its affordable beauty products.
Q: What is the new sales forecast for e.l.f. Beauty?
A: The new full-year net sales forecast is in the range of $1.60 billion to $1.61 billion.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles

04 Feb 2026
Generate Biomedicines Files for Nasdaq IPO